Choate Investment Advisors reduced its position in shares of Clorox Company (The) (NYSE:CLX) by 28.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,355 shares of the company’s stock after selling 930 shares during the period. Choate Investment Advisors’ holdings in Clorox Company (The) were worth $314,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Stevens Capital Management LP grew its position in shares of Clorox Company (The) by 44.2% during the 2nd quarter. Stevens Capital Management LP now owns 73,306 shares of the company’s stock valued at $9,767,000 after purchasing an additional 22,456 shares in the last quarter. Investment Centers of America Inc. grew its position in shares of Clorox Company (The) by 1.1% during the 2nd quarter. Investment Centers of America Inc. now owns 10,623 shares of the company’s stock valued at $1,411,000 after purchasing an additional 119 shares in the last quarter. Destination Wealth Management grew its position in shares of Clorox Company (The) by 9.8% during the 2nd quarter. Destination Wealth Management now owns 33,184 shares of the company’s stock valued at $4,421,000 after purchasing an additional 2,959 shares in the last quarter. Amalgamated Bank grew its position in shares of Clorox Company (The) by 56.0% during the 2nd quarter. Amalgamated Bank now owns 15,114 shares of the company’s stock valued at $2,014,000 after purchasing an additional 5,424 shares in the last quarter. Finally, Bahl & Gaynor Inc. grew its position in shares of Clorox Company (The) by 0.4% during the 2nd quarter. Bahl & Gaynor Inc. now owns 28,779 shares of the company’s stock valued at $3,454,000 after purchasing an additional 127 shares in the last quarter. Hedge funds and other institutional investors own 71.28% of the company’s stock.

A number of research analysts have recently commented on CLX shares. Deutsche Bank AG restated a “hold” rating and set a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday, September 12th. BidaskClub lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target for the company in a research report on Tuesday, July 4th. Finally, Royal Bank Of Canada restated a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research report on Friday, June 30th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $127.81.

COPYRIGHT VIOLATION WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/17/clorox-company-the-clx-stake-lowered-by-choate-investment-advisors.html.

Shares of Clorox Company (NYSE CLX) traded up 1.07% on Friday, reaching $136.18. 906,023 shares of the company traded hands. The stock has a 50-day moving average price of $135.92 and a 200 day moving average price of $135.24. The firm has a market capitalization of $17.58 billion, a P/E ratio of 25.53 and a beta of 0.40. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period last year, the company posted $1.30 EPS. The business’s revenue was up 2.9% on a year-over-year basis. Analysts anticipate that Clorox Company will post $5.66 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be paid a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.47%. Clorox Company (The)’s payout ratio is currently 63.04%.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of Clorox Company (The) stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP James E. Foster sold 9,861 shares of Clorox Company (The) stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Insiders sold a total of 21,242 shares of company stock valued at $2,944,449 over the last three months. Corporate insiders own 0.74% of the company’s stock.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.